A Novel Biomarker Discovery Solution to Personalize Drug Development

Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development. The core technology of the company is its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples. This technology is especially useful for late stage clinical drugs that have completed trials with unsatisfactory efficacy or side effect. By identifying biomarkers correlated to patients' responsiveness to drug candidates retrospectively, our technology enables biotech and pharmaceutical companies to design new clinical trials in targeted patient population to achieve higher efficacy and/or less adverse effects. Our platform can be broadly applied to biomarker discovery in most therapeutic areas, such as oncology, metabolic, cardiovascular, immunological, and neurological diseases.

A Personalized Medicine Company with Global Reach

---------------Denovo US San Diego Campus ---------------------------- Denovo China Beijing Clinical Center